Contents

Current Cancer Drug Targets, Volume 10 - Number 2

ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas

, 10(2): 127 - 134

S. Micuda, D. Rosel, A. Ryska and J. Brabek


DOI: 10.2174/156800910791054202




Understanding FOXO, New Views on Old Transcription Factors

, 10(2): 135 - 146

F. Zanella, W. Link and A. Carnero


DOI: 10.2174/156800910791054158




Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A

, 10(2): 147 - 154

A. Izzotti, M. Longobardi, C. Cartiglia, F. D'Agostini, S. Kanitz and S. De Flora


DOI: 10.2174/156800910791054220




Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

, 10(2): 155 - 167

A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer


DOI: 10.2174/156800910791054239




Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

, 10(2): 168 - 175

G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero and A. Nencioni


DOI: 10.2174/156800910791054211




Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

, 10(2): 176 - 191

R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio and M. Casto


DOI: 10.2174/156800910791054130




Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

, 10(2): 192 - 199

S. Colombo, A. Palmioli, C. Airoldi, R. Tisi, S. Fantinato, S. Olivieri, L. De Gioia, E. Martegani and F. Peri


DOI: 10.2174/156800910791054185




Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

, 10(2): 200 - 209

F. Navid, V. M. Santana and R. C. Barfield


DOI: 10.2174/156800910791054167




Inhibitors of HDACs - Effective Drugs Against Cancer?

, 10(2): 210 - 228

S. Muller and O. H. Kramer


DOI: 10.2174/156800910791054149




Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats

, 10(2): 229 - 241

Lunyin Yu, Hari G. Garg, Boyangzi Li, Robert J. Linhardt and Charles A. Hales


DOI: 10.2174/156800910791054176




The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

, 10(2): 242 - 267

M. Hingorani, C. Spitzweg, G. Vassaux, K. Newbold, A. Melcher, H. Pandha, R. Vile and K. Harrington


DOI: 10.2174/156800910791054194




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science